HealthCare Global Enterprises Limited has confirmed the status of its funds raised through a Rights Issue for the quarter ended March 31, 2026. The company successfully raised INR 424.68 crore, with all proceeds currently allocated according to the objects stated in the initial offer document. As of the end of the fourth quarter of the financial year, no deviations or variations in the utilization of these funds have been reported.
Quarterly Utilization Report
Following the Rights Issue allotment on March 27, 2026, HealthCare Global Enterprises Limited has maintained full transparency regarding the deployment of the INR 424.68 crore raised. The company has formally confirmed that the usage of these funds aligns strictly with the objects outlined in the February 24, 2026, Letter of Offer. The Audit Committee has reviewed these findings, ensuring total compliance with the planned financial objectives.
Breakdown of Fund Allocation
The total capital of INR 424.68 crore was earmarked for specific strategic initiatives. As of March 31, 2026, the allocation structure remains as follows:
- Pre-payment or repayment of borrowings: INR 170.00 crore
- Acquisition of 34% stake in Vizag Hospital and Cancer Research Center Private Limited: INR 154.04 crore
- General Corporate Purposes: INR 95.57 crore
- Issue-related expenses: INR 5.07 crore
The company reported that nil funds have been utilized against these specific heads as of the quarter end, and no variations or deviations in the use of proceeds have occurred. This stability in financial planning supports the company’s ongoing growth strategy in the healthcare sector.
Source: BSE
